Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Canton Strategic Holdings, Inc.THAR · Entity 6394 | Director · CEO | November 03, 2025 | November 06, 2025 |
| Hepion Pharmaceuticals, Inc.HEPA · Entity 8208 | Director · Chief Operating Officer | August 19, 2026 | August 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Canton Strategic Holdings, Inc.
Report date November 03, 2025 · Filed November 06, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $3.08 · Expires 2035-11-03 | Direct | 225,962 |
Reported balance
After 2025-11-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-11-03 · Grant · Acquired 20,000 · Balance 225,962 |
Hepion Pharmaceuticals, Inc.
Report date August 19, 2026 · Filed August 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $0.08 · Expires 2036-08-19 | Direct | 1,345,500 |
Reported balance
After 2026-08-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-08-19 · Grant · Acquired 1,345,500 · Balance 1,345,500 F1: 336,375 options vest upon grant and the remaining amount vests in equal amounts monthly over 6 months from date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: 336,375 options vest upon grant and the remaining amount vests in equal amounts monthly over 6 months from date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 19, 2026 Filed Aug 21, 2026 20:29 UTC | Hepion Pharmaceuticals, Inc. HEPA · Entity 8208 | GrantStock Options · Derivative | 1,345,500 | $0.00 Strike: $0.08 | $0.00 |
DisclosureSEC source: 0001493152-26-039688 · ownership.xml · derivative · entry 1 Appajosyula Sireesh · CIK 0001901565 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,345,500 Underlying: Common Stock · 1,345,500 shares Expires 2036-08-19 F1 · derivative.exercise_date: 336,375 options vest upon grant and the remaining amount vests in equal amounts monthly over 6 months from date of grant. Read SEC document |
| August 03, 2026 Filed Aug 13, 2026 01:36 UTC | Hepion Pharmaceuticals, Inc. HEPA · Entity 8208 | PurchaseWarrants · Derivative | 2,000,000 | $0.00 Strike: $0.06 | $0.00 |
DisclosureSEC source: 0001493152-26-037490 · ownership.xml · derivative · entry 2 Appajosyula Sireesh · CIK 0001901565 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,000,000 Underlying: Common Stock · 2,000,000 shares Expires 2031-08-03 Read SEC document |
| August 03, 2026 Filed Aug 13, 2026 01:36 UTC | Hepion Pharmaceuticals, Inc. HEPA · Entity 8208 | PurchaseCommon Stock | 2,000,000 | $0.05 | $100,000.00 |
DisclosureSEC source: 0001493152-26-037490 · ownership.xml · nonDerivative · entry 1 Appajosyula Sireesh · CIK 0001901565 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,250,000 Read SEC document |
| April 21, 2026 Filed Apr 27, 2026 10:24 UTC | Hepion Pharmaceuticals, Inc. HEPA · Entity 8208 | PurchaseCommon Stock, par value $0.0001 per share | 1,250,000 | $0.04 | $50,000.00 |
DisclosureSEC source: 0001493152-26-019028 · ownership.xml · nonDerivative · entry 1 Appajosyula Sireesh · CIK 0001901565 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,250,000 Read SEC document |
| November 03, 2025 Filed Nov 6, 2025 01:57 UTC | Canton Strategic Holdings, Inc. THAR · Entity 6394 | GrantStock Option · Derivative | 20,000 | $0.00 Strike: $3.08 | $0.00 |
DisclosureSEC source: 0001493152-25-020932 · ownership.xml · derivative · entry 1 Appajosyula Sireesh · CIK 0001901565 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,962 Underlying: Common Stock · 20,000 shares Expires 2035-11-03 Read SEC document |
| August 04, 2025 Filed Aug 6, 2025 21:04 UTC | Canton Strategic Holdings, Inc. THAR · Entity 6394 | GrantStock Option · Derivative | 90,000 | $0.00 Strike: $1.33 | $0.00 |
DisclosureSEC source: 0001641172-25-022450 · ownership.xml · derivative · entry 1 Appajosyula Sireesh · CIK 0001901565 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,962 Underlying: Common Stock · 90,000 shares Expires 2035-08-04 F1 · derivative.exercise_date: 45,000 of the stock options vest on date of grant and 45,000 vest on August 4, 2026. Read SEC document |
| June 20, 2025 Filed Jun 23, 2025 23:31 UTC | Canton Strategic Holdings, Inc. THAR · Entity 6394 | PurchaseCommon Stock | 690 | $1.42 | $979.80 |
DisclosureSEC source: 0001641172-25-016168 · ownership.xml · nonDerivative · entry 2 Appajosyula Sireesh · CIK 0001901565 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,868 Read SEC document |
| June 20, 2025 Filed Jun 23, 2025 23:31 UTC | Canton Strategic Holdings, Inc. THAR · Entity 6394 | PurchaseCommon Stock | 60,806 | $1.48 | $89,992.88 |
DisclosureSEC source: 0001641172-25-016168 · ownership.xml · nonDerivative · entry 1 Appajosyula Sireesh · CIK 0001901565 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,178 Read SEC document |
| January 13, 2025 Filed Jan 14, 2025 21:38 UTC | Canton Strategic Holdings, Inc. THAR · Entity 6394 | GrantOptions (right to buy) · Derivative | 52,875 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001493152-25-002165 · ownership.xml · derivative · entry 1 Appajosyula Sireesh · CIK 0001901565 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,962 Underlying: Common Stock · 52,875 shares Expires 2035-01-13 F1 · derivative.exercise_date: On January 13, 2025, the Reporting Person was granted options ("Options") to purchase up to 52,875s shares of the Registrant's common stock pursuant to the Registrant's 2023 Omnibus Equity Incentive Plan. The Options vested in full upon grant. Read SEC document |
| November 13, 2024 Filed Nov 13, 2024 22:06 UTC | Canton Strategic Holdings, Inc. THAR · Entity 6394 | PurchaseCommon Stock | 5,000 | $2.02 | $10,096.00 |
DisclosureSEC source: 0001493152-24-045180 · ownership.xml · nonDerivative · entry 1 Appajosyula Sireesh · CIK 0001901565 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,758 Read SEC document |
| October 08, 2024 Filed Oct 8, 2024 20:10 UTC | Canton Strategic Holdings, Inc. THAR · Entity 6394 | PurchaseCommon Stock | 5,000 | $1.93 | $9,650.00 |
DisclosureSEC source: 0001493152-24-040439 · ownership.xml · nonDerivative · entry 1 Appajosyula Sireesh · CIK 0001901565 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,364 Read SEC document |
| October 08, 2024 Filed Oct 9, 2024 13:58 UTC Amendment | Canton Strategic Holdings, Inc. THAR · Entity 6394 | PurchaseCommon Stock | 5,000 | $1.93 | $9,650.00 |
DisclosureSEC source: 0001493152-24-040544 · ownership.xml · nonDerivative · entry 1 Appajosyula Sireesh · CIK 0001901565 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,758 Read SEC document |
| August 09, 2024 Filed Aug 12, 2024 21:18 UTC | Canton Strategic Holdings, Inc. THAR · Entity 6394 | GrantOptions (right to buy) · Derivative | 38,087 | $0.00 Strike: $2.93 | $0.00 |
DisclosureSEC source: 0001493152-24-031369 · ownership.xml · derivative · entry 1 Appajosyula Sireesh · CIK 0001901565 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,087 Underlying: Common stock · 38,087 shares Expires 2034-08-09 F1 · derivative.exercise_date: On August 9, 2024, the Reporting Person was granted options ("Options") to purchase up to 38,087 shares of the Registrant's common stock pursuant to the Registrant's 2023 Omnibus Equity Incentive Plan. The Options vest in 12 equal monthly installments with the first installment vesting on the date of grant. Read SEC document |
| November 07, 2023 Filed Nov 10, 2023 00:52 UTC | Canton Strategic Holdings, Inc. THAR · Entity 6394 | GrantOptions (right to buy) · Derivative | 25,000 | $0.00 Strike: $0.16 | $0.00 |
DisclosureSEC source: 0001493152-23-040170 · ownership.xml · derivative · entry 1 Appajosyula Sireesh · CIK 0001901565 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common stock · 25,000 shares Expires 2033-11-07 F1 · derivative.exercise_date: On November 7, 2023, the Reporting Person was granted options ("Options") to purchase up to 25,000 shares of the Registrant's common stock pursuant to the Registrant's 2023 Omnibus Equity Incentive Plan. The Options vest in 12 equal monthly installments with the first installment vesting on the date of grant. Read SEC document |
| July 14, 2022 Filed Jul 18, 2022 20:15 UTC | Canton Strategic Holdings, Inc. HILS · Entity 6394 | GiftCommon Stock | 7,576 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-019586 · ownership.xml · nonDerivative · entry 2 Appajosyula Sireesh · CIK 0001901565 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,576 F2 · ownership.nature: The shares of common stock are owned by Channel BioConsulting, LLC. Sireesh Appajosyula is the Managing Member of Channel BioConsulting, LLC and in such capacity has the right to vote and dispose of the securities held by such entity. Read SEC document |
| July 14, 2022 Filed Jul 18, 2022 20:15 UTC | Canton Strategic Holdings, Inc. HILS · Entity 6394 | GiftCommon Stock | 75,757 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-019586 · ownership.xml · nonDerivative · entry 1 Appajosyula Sireesh · CIK 0001901565 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · ownership.nature: The shares of common stock were owned by Mercer Lake Group LLC. Sireesh Appajosyula is the Managing Member of Mercer Lake Group LLC and in such capacity had the right to vote and dispose of the securities held by such entity. Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 20:15 UTC | Canton Strategic Holdings, Inc. HILS · Entity 6394 | GrantOptions (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.33 | $0.00 |
DisclosureSEC source: 0001493152-22-007543 · ownership.xml · derivative · entry 1 Appajosyula Sireesh · CIK 0001901565 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common stock · 50,000 shares Expires 2032-03-21 F1 · derivative.exercise_date: On March 21, 2022, the Reporting Person was granted options ("Options") to purchase up to 50,000 shares of the Registrant's common stock pursuant to the Registrant's 2019 Stock Incentive Plan. The Options vest in 12 equal monthly installments with the first installment vesting on the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.